PAOG Announces CEO Interview Discussing Cannabis Investigational New Drug Application Plans With FDA
SANDUSKY, Ohio, Oct. 2, 2020 /PRNewswire/ — PAO Group, Inc. (USOTC: PAOG) today announced an interview of CEO Jim DiPrima on MoneyTV where Mr. DiPrima discusses recent news regarding PAOG’s latest moves to engage a contract research organization (CRO) to advance an investigational New Drug application (IND) with the Food ... Read More